LabCompass

Marcos de Lima

Medicine · The Ohio State University

Established · publishing since 1996

Publications

861

Citations

23,172

Est. group size

~41

Recurring co-author estimate

Active years

31

Publishing since 1996

Research summary
AI-generated

Marcos de Lima works on treatments for blood cancers such as leukemia and lymphoma, with a focus on stem cell (bone marrow) transplantation and CAR T-cell therapy, which involves engineering a patient's own immune cells to attack cancer. His work frequently draws on large multi-center patient registries (such as CIBMTR) to study transplant outcomes, drug safety, and complications of cell-based therapies.

Stem cell (bone marrow) transplantationCAR T-cell therapy for blood cancersLeukemia and lymphoma treatment outcomesRegistry-based clinical outcomes researchTransplant-related toxicity and complication management

Publication output has fluctuated over the last decade with a peak around 2023, but has settled to a somewhat lower and steady pace in the most recent years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 30.6/year recently
2017: 35 publications172018: 45 publications182019: 51 publications192020: 62 publications202021: 38 publications212022: 27 publications222023: 66 publications66232024: 27 publications242025: 31 publications252026: 2 publications26
Recent publications
Publishes in
  • Blood×99
  • Biology of Blood and Marrow Transplantation×57
  • Transplantation and Cellular Therapy×29
  • Bone Marrow Transplantation×24
  • Clinical Lymphoma Myeloma & Leukemia×15
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile